Cargando…
The Wilms’ tumor gene-1 is a prognostic factor in myelodysplastic syndrome: a meta analysis
Previous studies have suggested that Wilms’ tumor gene-1 (WT1) may be related to a decrease in both relapse-free survival (RFS) and overall survival (OS) for patients with myelodysplastic syndrome (MDS). Therefore, we conducted a meta-analysis on the utility of WT1 as a prognostic indicator of MDS....
Autores principales: | Jiang, Yanan, Liu, Lin, Wang, Jinhuan, Cao, Zeng, Zhao, Zhigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882328/ https://www.ncbi.nlm.nih.gov/pubmed/29662637 http://dx.doi.org/10.18632/oncotarget.23671 |
Ejemplares similares
-
Prognostic role of TET2 deficiency in myelodysplastic syndromes: A meta-analysis
por: Lin, Yun, et al.
Publicado: (2017) -
Loss of heterozygosity on chromosome 16q increases relapse risk in Wilms’ tumor: a meta-analysis
por: Pan, Zhenyu, et al.
Publicado: (2017) -
Prognostic role of DEK in human solid tumors: a meta-analysis
por: Liu, Gang, et al.
Publicado: (2017) -
E-cadherin expression as a prognostic factor in patients with ovarian cancer: a meta-analysis
por: Dai, Chencheng, et al.
Publicado: (2017) -
Prognostic significance of U2AF1 mutations in
myelodysplastic syndromes: a meta-analysis
por: Li, Bixia, et al.
Publicado: (2019)